Login


TI Ref No : 526380668
Description : Openhousebiologics Discount Agreements 202535 Natalizumab (dosage Form For Intravenous Use)
Date : 2025-12-18
Deadline : 2026-06-16
Document Type : Tenders
View Details
Whats app